Molecular docking study on anticancer activity of plant-derived natural products

Medicinal Chemistry Research

Volumn 19, Issue 8, 2010, Pages 817-835

  Phosrithong, Narumol ^a   Ungwitayatorn, Jiraporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anticancer; Docking; Natural products

Indexed keywords

ANTINEOPLASTIC AGENT; APIGENIN; BAICALEIN; BIOCHANIN A; CATECHIN; CHRYSIN; COUMESTROL; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; DAIDZEIN; DIOSMETIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); EMODIN; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; EQUOL; FISETIN; FLAVOPIRIDOL; GALANGIN; GENISTEIN; GUANINE QUADRUPLEX; LUPEOL; NATURAL PRODUCT; PLANT EXTRACT; PROTEIN BCL 2; QUERCETIN; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING ASSAY; COMPUTER SIMULATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; MOLECULAR DOCKING; MOLECULAR MODEL; PARAMETER; TELOMERE;

EID: 78650753990     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9233-5     Document Type: Article

References (34)

1. Ahmad N, Cheng P, Mukhtar H (2000) Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 275:328-334
2. Ahn Y, Vogeti L, Liu C, Santhapuram H, White J, Vasandani V (2007) Design, synthesis, antiproliferative and CDK2-cyclin A inhibitory activity of novel flavopiridol analogues. Bioorg Med Chem 15:702-713
3. Alessi F, Quarta S, Savio M, Riva F, Rossi L, Stivala LA, Scovassi AI, Meijer L, Prosperi E (1998) The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp Cell Res 245:8-18
4. Been MD, Champoux JJ (1984) Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing. J Mol Biol 180:515-532
5. Berger SJ, Gupta S, Belfi CA, Gosky DM, Mukhtar H (2001) Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem Biophys Res Commun 288:101-105
6. Constantinou A, Mehta R, Runyan C, Rao K, Vaughan A, Moon R (1995) Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod 58:217-225
7. Dai Y, Grant S (2003) Cyclin-dependent kinase inhibitors. Curr Opin Pharmacol 3:362-370
8. Estrada E, Uriarte E, Montero A, Teijeira M, Santana L, De Clercq E (2000) A novel approach for the virtual screening and rational design of anticancer compounds. J Med Chem 43:1975-1985
9. Ferriola PC, Cody V, Middleton E Jr (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38:1617-1624
10. Gomez D, Lemarteleur T, Lacroix L, Mailliet P, Mergny J, Riou J (2004) Telomerase down regulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res 32:371-379
11. Haider SM, Parkinson GN, Neidle S (2003) Structure of a G-quadruplex-ligand complex. J Mol Biol 326:117-125
12. Hatipoglu A, Basaran A, Dikmen M, Cosan D, Gunes HV, Degirmenci I (2007) Effects of quercetin on apoptosis and telomerase activity in NIH-3T3 cell lines compared with tamoxifen. Acta Physiol 190(Suppl 656):P44
13. Huang Z (2000) Bcl-2 family proteins as targets for anticancer drug design. Oncogene 19:6627-6631
14. Huwe A, Mazitschek R, Giannis A (2003) Small molecules as inhibitors of cyclin-dependent kinases. Angew Chem Int Ed Engl 42:2122-2138
15. Jo J, Mejia E, Lila M (2006) Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols. J Agric Food Chem 54:2083-2087
16. Kawakami K, Futami H, Takahara J, Yamaguchi K (1996) UCN-01, 7-Hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem Biophys Res Commun 219:778-783
17. Kim M-Y, Gleason-Guzman M, Izbicka E, David Nishioka D, Hurley LH (2003) The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Res 63:3247-3256
18. Lauria A, Ippolito M, Almerico AM (2007) Molecular docking approach on the topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database. J Mol Model 3:393-400
19. Leone M, Zhai D, Sareth S, Kitada S, Reed JC, Pellecchia M (2003) Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 2003(63):8118-8121
20. Losiewicz MD, Carlson BA, Kaur G, Sausville EA, Worland PJ (1994) Potent inhibition of Cdc2 kinase activity by the flavonoid L86-8275. Biochem Biophys Res Commun 201:589-595
21. Lu H, Chang DJ, Baratte B, Meijer L, Schulze-Gahmen U (2005) Crystal structure of a human cyclindependent kinase 6 complex with a flavonol inhibitor, fisetin. J Med Chem 48:737-743
22. Mares M, Chandra S, Mejia E (2004) In vitro chemopreventive activity of Camellia sinensis, Ilex paraguariensis and Ardisia compressa tea extracts and selected polyphenols. Mutat Res 554:53-65
23. Meijer L, Borgne A, Mulner O (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243: 527-536
24. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639-1662
25. Ono K, Nakane H, Fukushima M, Chermann J-C, Barre-Sinoussi F (1990) Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 190:469-476
26. Patel DJ, Phan AT, Kuryavyi V (2007) Human telomere, oncogenic promoter and 50-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res 35(22):7429-7455
27. Pham N-A, Jacobberger JW, Schimmer AD, Cao P, Gronda M, Hedley DW (2004) The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibit tumor growth in severe combined immunodeficient mice. Mol Cancer Ther 3:1239-1248
28. Pommier Y (1998) Diversity of DNA topoisomerases I and inhibitors. Biochimie 80:255-270
29. Salti G, Grewal S, Mehta R, das Gupta T, Boddie A Jr, Constantinou A (2000) Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur J Cancer 36: 796-802
30. Snyder R, Gillies P (2003) Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids. Food Chem Toxicol 41:1291-1298
31. Sonpavde G, Hutson T (2007) Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Curr Oncol Rep 9:115-119
32. Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK (1996) Flk-1 as a target for tumor growth inhibition. Cancer Res 56:3540-3545
33. Wang Y-C, Bachrach U (2002) The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Amino acids 22:131-143
34. Wang G, Coleska Z, Yang C, Wang R, Tang G, Guo J (2006) Structure-based design of potent smallmolecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem 49:6139-6142